Small fibers, large impact: quality of life in small-fiber neuropathy.
Mayienne Bakkers, Catharina G Faber, Janneke G J Hoeijmakers...
https://pubmed.ncbi.nlm.nih.gov/23716362/Actively Recruiting
Led by Istituti Clinici Scientifici Maugeri SpA · Updated on 2026-04-17
280
Participants Needed
9
Research Sites
13 weeks
Total Duration
Researchers are examining how different types of pain and autonomic symptoms affect people diagnosed with Parkinsons disease PD and multiple system atrophy MSA receiving care at Maugeri Clinical Scientific Institutes. The study aims to evaluate the prevalence and characteristics of pain and autonomic dysfunction, assess how rehabilitation impacts these symptoms, and understand their effect on quality of life for both inpatients and outpatients. All participants will receive a neurological exam and participate in a rehabilitation program designed to improve strength, coordination, balance, endurance, and daily living skills. Clinical scales will be used to assess disease stage, severity, motor and non-motor symptoms, cognitive function, depression, autonomic dysfunction, pain, and quality of life. The study compares patients with PD and MSA and measures outcomes before and after an average 30-day rehabilitation period. Participants will undergo evaluations at recruitment and after completing rehabilitation, including assessments of pain and autonomic symptoms. Researchers will monitor changes in clinical scores and quality of life throughout the study. This observational study will provide insights to help clinicians better manage disability and tailor rehabilitation strategies to improve patients well-being over the course of their care.
CONDITIONS
Pain and Autonomic Symptoms in Parkinson's Disease and Atypical Parkinsonisms
M
Maria Nolano, MD, PhD
G
Giuseppe Caporaso
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Istituti Clinici Scientifici Maugeri SpA
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Approximately 30 days
Participants undergo a rehabilitation program to improve strength, coordination, balance, endurance, and the ability to perform activities of daily life, along with clinical scale assessments for disease stage, clinical severity, motor and non-motor impairment, cognitive impairment, depression, quality of life, autonomic dysfunction, and pain.
Baseline evaluation and ongoing rehabilitation visits
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Mayienne Bakkers, Catharina G Faber, Janneke G J Hoeijmakers...
https://pubmed.ncbi.nlm.nih.gov/23716362/S Gilman, G K Wenning, P A Low...
https://pubmed.ncbi.nlm.nih.gov/18725592/Ronald B Postuma, Daniela Berg, Matthew Stern...
https://pubmed.ncbi.nlm.nih.gov/26474316/Mayela Rodríguez-Violante, Alonso Alvarado-Bolaños, Amin Cervantes-Arriaga...
https://pubmed.ncbi.nlm.nih.gov/30363423/Masato Asahina, Ekawat Vichayanrat, David A Low...
https://pubmed.ncbi.nlm.nih.gov/22942216/K Ray Chaudhuri, A Rizos, C Trenkwalder...
https://pubmed.ncbi.nlm.nih.gov/26096067/Jan Linder, Hans Stenlund, Lars Forsgren
https://pubmed.ncbi.nlm.nih.gov/20108376/Maria Nolano, Vincenzo Provitera, Anna Estraneo...
https://pubmed.ncbi.nlm.nih.gov/18515869/Birgitta H Quittenbaum, Birgitta Grahn
https://pubmed.ncbi.nlm.nih.gov/15036166/Peter Valkovic, Michal Minar, Helena Singliarova...
https://pubmed.ncbi.nlm.nih.gov/26309254/Istituti Clinici Scientifici Maugeri SpA
Lead Sponsor